Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer
Breast Cancer
About this trial
This is an interventional screening trial for Breast Cancer focused on measuring ductal breast carcinoma in situ, lobular breast carcinoma in situ
Eligibility Criteria
DISEASE CHARACTERISTICS: Increased risk of breast cancer as determined by 1 or more first-degree relatives (mother, sister, or daughter) with a history of breast cancer OR a personal history of atypical hyperplasia, lobular carcinoma in situ, or ductal carcinoma in situ of the breast OR No increased risk of breast cancer as determined by a lack of the above conditions Scheduled to undergo elective breast surgery for removal of a mammographic lesion or palpable breast lump No prior bilateral mastectomy or bilateral breast irradiation Hormone receptor status: Not specified PATIENT CHARACTERISTICS: Age: 30 and over Sex: Female Menopausal status: Not specified Performance status: Not specified Life expectancy: Not specified Hematopoietic: Not specified Hepatic: Not specified Renal: Not specified Other: No active invasive malignancy in any site except basal cell or squamous cell skin cancer No significant medical or psychiatric problems that would preclude study No evidence of excessive use of narcotics or drug dependency PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: Not specified Endocrine therapy: Not specified Radiotherapy: See Disease Characteristics Surgery: See Disease Characteristics